跳至主要内容
临床试验/NCT02921711
NCT02921711已完成不适用

TRAIL: Treatment of Intracranial Aneurysms With LVIS® System

Microvention-Terumo, Inc.0 个研究点目标入组 90 人开始时间: 2012年6月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
90
主要终点
Retreatment rate

研究概览

简要总结

A prospective, multicenter, observational assessment of the safety and effectiveness of the LVIS® device in the treatment of wide necked intracranial aneurysms.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patient or patient's legally authorized representative has been informed about the confidentiality of the study and has agreed to the collection of his/her personal data
  • Patient has a ruptured or unruptured intracranial aneurysm for which:
  • The parent artery has a diameter ≥ 2.0mm and ≤ 4.5 mm;
  • The aneurysm neck size is ≥ 4mm or its dome-to-neck ratio is < 2 (wide neck)
  • Endovascular treatment with coils and one or more LVIS® devices has been determined necessary for the patient by the multidisciplinary team
  • Patient is aged ≥ 18 years
  • Patient presents with a WFNS score between 0 and 3
  • Patient has agreed to attend follow-up appointments

排除标准

  • The use of an endovascular stent other than LVIS® has been determined necessary
  • Patient presents with medical or surgical co-morbidities limiting his/her life expectancy to less than one year
  • Patient has a contraindication to platelet inhibition treatment
  • Patient requires retreatment of an aneurysm previously treated with a stent
  • Patient is pregnant
  • Patient has multiple aneurysms to be treated in one procedure

结局指标

主要结局

Retreatment rate

时间窗: 18 months

Mortality rate

时间窗: 18 months

Morbidity rate

时间窗: 18 months

Anatomical stability of aneurysm treatment compared to the initial occlusion rate of the aneurysm

时间窗: 18 months

次要结局

未报告次要终点

研究者

发起方
Microvention-Terumo, Inc.
申办方类型
Industry
责任方
Sponsor

相似试验